77-year-old patient with squamous NSCLC who had previously received carboplatin plus ... We recently presented encouraging efficacy and safety data at ESMO on NUC-7738 plus pembrolizumab in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback